首页> 外国专利> New Compound, Process for its productionIts use as a Marker and a method for the assessment of the Purity or stability to degradation or a sample that includes pharmaceutical dosage Lamotrigine Lamotrigine

New Compound, Process for its productionIts use as a Marker and a method for the assessment of the Purity or stability to degradation or a sample that includes pharmaceutical dosage Lamotrigine Lamotrigine

机译:新化合物及其生产方法用作标记和评估纯度或对降解稳定性的方法或包括药物剂量的样品Lamotrigine Lamotrigine

摘要

Describes the N - (5 - 6 - amino - (2,3-dichlorophenyl) - 1,3,5-triazine 1,2,4 - 3 - yl) - 2.3 - diclorobenzamida, a New process for its productionIts use as a marker for the assessment of the Purity ymu00e9todo or stability to Degradation of a sample or a pharmaceutical dosage Lamotrigine comprendelamotrigina,Evaluating the sample selected from a compound of 3 - amino - 4 - (2,3-dichlorophenyl) - 1,3,5-triazine 1,2,4 - 5 - (4H) - one and N - (3 - amino - 4 - (2,3-dichlorophenyl) - 1,3,5-triazine 1,2,4 - 3 - yl) - 2.3 - diclorobenzamida.
机译:描述了N-(5-6-氨基-(2,3-二氯苯基)-1,3,5-三嗪1,2,4-3-yl)-2.3-二氯罗宾米达,一种新的生产方法评估样品纯度或降解稳定性或药物剂量Lamotrigine comprendelamotrigina的标记,评估选自3-氨基-4-(2,3-二氯苯基)-1,3的化合物的样品, 5-三嗪1,2,4-5-(4H)-1和N-(3-氨基-4-(2,3-二氯苯基)-1,3,5-三嗪1,2,4-3-yl )-2.3-diclorobenzamida。

著录项

  • 公开/公告号AR014074A1

    专利类型

  • 公开/公告日2001-01-31

    原文格式PDF

  • 申请/专利权人 THE WELLCOME FOUNDATION LIMITED;

    申请/专利号AR1999P101018

  • 发明设计人

    申请日1999-03-10

  • 分类号G01N30/00;G01N30/22;G01N30/36;G01N30/90;G01N33/15;C07D253/06;

  • 国家 AR

  • 入库时间 2022-08-22 01:26:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号